Back to Search
SYED AHMAD, M.D./ RHEUMATOLOGIST
M.D./ RHEUMATOLOGIST
Specialist
NPI: 1487654182Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
0101036550(VA)
Research & Publications (20)
Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.
PMID 19118270·Chest·2009
4-observational
Effects of endurance exercise on ventral tegmental area neurons in the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and probenecid-treated mice.
PMID 19084578·Neurosci Lett·2009
7-preclinical
Sequence-dependence and prediction of nucleotide solvent accessibility in double stranded DNA.
PMID 18955120·Gene·2009
8-other
Protein-DNA interactions: structural, thermodynamic and clustering patterns of conserved residues in DNA-binding proteins.
PMID 18801847·Nucleic Acids Res·2008
8-other
Raising taxes to reduce smoking prevalence in the US: a simulation of the anticipated health and economic impacts.
PMID 17610918·Public Health·2008
8-other
Shift in the burden of cancer towards older people--a retrospective population-based study.
PMID 17504355·Int J Clin Pract·2007
8-other
Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.
PMID 17356077·Chest·2007
8-other
Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis.
PMID 16946136·Circ Res·2006
8-other
Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
PMID 16229474·Biochemistry·2005
8-other
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
PMID 15472115·Circ Res·2004
7-preclinical
Toxicological studies on Lactose Oxidase from Microdochium nivale expressed in Fusarium venenatum.
PMID 15135207·Regul Toxicol Pharmacol·2004
7-preclinical
Adverse drug event monitoring at the Food and Drug Administration.
PMID 12534765·J Gen Intern Med·2003
8-other
Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
PMID 14511240·Immunology·2003
7-preclinical
Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
PMID 12220193·Biochemistry·2002
8-other
Renal failure associated with the use of celecoxib and rofecoxib.
PMID 12093311·Drug Saf·2002
6-review
Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
PMID 12586132·Thromb Res·2002
3-trial
Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist.
PMID 11323025·Thromb Res·2001
4-observational
Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates.
PMID 11053616·Thromb Res·2000
4-observational
Structural and functional characterization of platelet receptor-mediated factor VIII binding.
PMID 10777612·J Biol Chem·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11 WESTWOOD MEDICAL PARK
BLUEFIELD, VA 24605 - Phone
- (276) 326-2638
Quick Facts
- NPI
- 1487654182
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile